# Apyx Medical (APYX) — Earnings

APYX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/apyx/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.07 |
| EPS estimate | −$0.08 |
| EPS surprise | +14.63% |
| Revenue surprise | +5.38% |
| Revenue | $13.9M |
| Revenue estimate | $13.2M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/719135/000143774926026346/apyx20260630_10q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/bfb3adfa-b446-9181-2335-921eb56bfd92.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | −$0.08 | −$0.07 | 14.63% | $13.2M | $13.9M |
| Q1 2026 | May 7, 2026 | −$0.11 | −$0.05 | 54.55% | $10.8M | $12.5M |
| Q4 2025 | Mar 10, 2026 | −$0.06 | −$0.03 | 45.45% | $18.5M | $19.2M |
| Q3 2025 | Nov 6, 2025 | −$0.10 | −$0.05 | 51.17% | $12.0M | $12.9M |
| Q2 2025 | Aug 7, 2025 | −$0.09 | −$0.09 | 3.54% | $11.7M | $11.4M |
| Q1 2025 | May 8, 2025 | −$0.12 | −$0.10 | 16.67% | $9.4M | $9.4M |
| Q4 2024 | Mar 13, 2025 | −$0.16 | −$0.12 | 24.81% | $13.4M | $14.2M |
| Q3 2024 | Nov 8, 2024 | −$0.18 | −$0.14 | 23.91% | $11.4M | $11.5M |
| Q2 2024 | Aug 8, 2024 | −$0.20 | −$0.19 | 4.04% | $11.8M | $12.1M |
| Q1 2024 | May 9, 2024 | −$0.22 | −$0.22 | -1.85% | $9.5M | $10.2M |
| Q4 2023 | Mar 21, 2024 | −$0.18 | −$0.28 | -57.30% | $14.9M | $14.7M |
| Q3 2023 | Nov 9, 2023 | −$0.11 | −$0.13 | -14.04% | $15.4M | $12.0M |
| Q2 2023 | Aug 10, 2023 | −$0.07 | −$0.03 | 57.14% | $14.3M | $13.6M |
| Q1 2023 | May 11, 2023 | −$0.14 | −$0.10 | 25.93% | $10.8M | $12.1M |
| Q4 2022 | Mar 16, 2023 | −$0.14 | −$0.17 | -19.30% | $12.9M | $12.6M |
| Q3 2022 | Nov 10, 2022 | −$0.15 | −$0.17 | -17.24% | $12.0M | $9.1M |
| Q2 2022 | Aug 11, 2022 | −$0.19 | −$0.16 | 14.67% | $10.6M | $10.3M |
| Q1 2022 | May 12, 2022 | −$0.15 | −$0.17 | -15.88% | $11.1M | $12.5M |
| Q4 2021 | Mar 17, 2022 | −$0.11 | −$0.06 | 45.45% | $14.6M | $16.8M |
| Q3 2021 | Nov 12, 2021 | −$0.15 | −$0.12 | 20.00% | $10.2M | $11.8M |

## Frequently Asked Questions

### When did Apyx Medical (APYX) last report earnings?

Apyx Medical last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did APYX beat earnings estimates?

Yes. Apyx Medical reported EPS of −$0.07 for Q2 2026 against a −$0.08 estimate — a 14.63% beat.

### How much revenue did APYX report last quarter?

Apyx Medical reported $13.9M in revenue for Q2 2026, against a consensus estimate of $13.2M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).